期刊文献+

MicroRNA在狼疮性肾炎免疫发病机制中的新认识 被引量:1

下载PDF
导出
摘要 系统性红斑狼疮( systemic lupus erythematosus,SLE)是由于机体免疫耐受缺失而引起的自身免疫性疾病,通常伴随免疫复合物性肾小球肾炎[1]。系膜细胞在肾小球局部发挥着重要的免疫调节作用,在病理状态下由于免疫复合物( immune com-plex,IC)的沉积而激活,并释放出各类炎症因子从而引起巨噬细胞、B细胞、T细胞和树突状细胞( DCs )侵润,进一步放大炎症效应及加重肾脏损害[2]。
出处 《中国中西医结合肾病杂志》 2015年第4期357-360,共4页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 国家重点基础研究发展计划项目(973计划)(No.2012CB517602) 国家自然科学基金资助项目(No.81370794) "十二五"国家科技支撑计划项目(No.2011BAI10B04)
  • 相关文献

参考文献39

  • 1叶彬娴,倪兆慧.狼疮性肾炎的治疗现状及进展[J].中国中西医结合肾病杂志,2012,13(2):167-169. 被引量:19
  • 2Seret G, Le MY, Renaudineau Y, et al. Mesangial cell - specific antibodies are central to the pathogenesis of lupus nephritis. Clin Dev Immunol,2012 ,2012 :579670.
  • 3Yung S, Chan TM. Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown. Clin Dev Immunol,2012,2012 : 139365.
  • 4Liu CL, Tangsombatvisit S, Rosenberg JM, et al. Specific post - translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies. Ar- thritis Res Ther, 2012,14 ( 1 ) : R25.
  • 5Jeffries MA, Sawalha AH. Epigenetics in systemic lupus erythe- matosus:leading the way for specific therapeutic agents. Int J Clin Rheumto1,2011,6 (4) :423 - 439.
  • 6Dai R, Ahmed SA. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res,2011,157(4) :163 - 179.
  • 7Vinuesa CG, Rigby R J, Yu D. Logic and extent of miRNA - me- diated control of autoimmune gene expression, lnt Rev Immunol, 2009,28(3 -4) :112 -138.
  • 8Dai Y, Sui W, Lan H, et al. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int ,2009,29 ( 7 ) :749 - 754.
  • 9Dai Y, Huang YS, Tang M, et al. Microarray analysis of mieroR- NA expression in peripheral blood cells of systemic lupus erythe- matosus patients. Lupus ,2007,16 ( 12 ) :939 - 946.
  • 10Denby L,Ramdas V,Mcbride MW,et al. miR -21 and miR - 214 are consistently modulated during renal injury in rodent models. Am J Pathol,2011,179(2) :661 -672.

二级参考文献26

  • 1Cameron JS. Lupus nephritis[J].Journal of the American Society of Nephrology,1999.413-424.
  • 2Cervera R,Khamashta MA,Font J. Morbidity and mortality in systemic lupus erythematosus during a 10-year period:a comparison of early and late manifestations in a cohort of 1 000 patients[J].Medicine(Baltimore),2003,(05):299-308.doi:10.1097/01.md.0000091181.93122.55.
  • 3Austin HA,Klippel JH,Balow JE. Therapy of lupus nephritis.Controlled trial of prednisone and cytotoxic drugs[J].New England Journal of Medicine,1986,(10):614-619.doi:10.1056/NEJM198603063141004.
  • 4Boumpas DT,Austin HA 3rd,Vaughn EM. Controlled trial of usle methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis[J].The Lancet,1992,(8822):741-745.
  • 5Gourley MF,Austin HA 3rd,Scott D. Methylprednisolone and cyclophosphamide,alone or in combination,in patients with lupus nephritis.A randomized,controlled trial[J].Annals of Internal Medicine,1996,(07):549-557.
  • 6Dooley MA,Hogan S,Jennette C. Cyclophosphamide therapy for lupus nephritis:poor renal survival in black Americans[J].Kidney International,1997,(04):1188-1195.
  • 7Gourley MF,Austin HA 3rd,Scott D. Methylprednisolone and cyclophosphamide,alone or in combination,in patients with lupus nephritis.A randomized,controlled trial[J].Annals of Internal Medicine,1996,(07):549-557.
  • 8Houssiau FA,Vasconcelos V,D′Cruz D. Immunosuppressive therapy in lupus nephritis:the Euro-Lupus Nephritis Trial,a randomized trial of low-dose versus high-dose intravenous cyclophosphamide[J].Arthritis and Rheumatism,2002,(08):2121-2131.doi:10.1002/art.10461.
  • 9Houssiau FA,Vasconcelos C,D′Cruz D. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide[J].Annals of the Rheumatic Diseases,2010,(01):61-64.
  • 10Grootscholten C,Ligtenberg G,Hagen EC. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis.A randomized controlled trial[J].Kidney International,2006,(04):732-742.doi:10.1038/sj.ki.5001630.

共引文献18

同被引文献8

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部